GENE ONLINE|News &
Opinion
Blog

Opdivo
Bristol Myers Scores FDA Approval for Opdivo-Yervoy Combination as First-Line HCC Therapy
2025-04-14
Taiwan Greenlights BMS, Ono’s Opdivo For Frontline Esophageal Cancer
2022-07-20
BMS’s Drug Bags First FDA-Approved Immunotherapy Tag for Initial Treatment of Gastric Cancer
2021-04-19
BMS’s Combo Therapy Involving LAG-3 Drug Impresses in Melanoma Trial
2021-03-27
FDA Accepts Opdivo, Cabometyx Combo’s Priority Review Applications
2020-10-21
FDA Approves Treatment for Aggressive Form of Mesothelioma After Sixteen Long Years
2020-10-04
BMS Enters Esophageal Cancer Therapy Area Amidst High Competition
2020-09-27
LATEST
Ambarella to Present The Ambarella Edge Initiative on Physical AI at Embedded World 2026
2026-02-09
GXO Logistics to Manage Operations at BMW Group’s Swindon Site
2026-02-09
Trip.com Group Limited to Release Q4 and Full-Year 2025 Financial Results on February 25, 2026
2026-02-09
FireFox Gold Reports 54.91 g/t Gold Over 1.95 Meters in Northeast Zone Expansion at Mustajärvi Project
2026-02-09
TotalEnergies to Supply Google with 1 GW of Solar Energy for Texas Data Centers Over 15 Years
2026-02-09
TrumpRx Enters Pharmaceutical Market as Novo Nordisk Plans Super Bowl Ad for Oral Wegovy
2026-02-09
VHH Antibodies Derived from Camelids Show Potential for Targeted Therapies Despite Stability Challenges
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top